Cytodyn Inc (CYDY)

[$5.95akadawson-m]

I would like to make something really clear. I agree completely with Blueheel1 regarding Cyrus’s purchase of CYDY stock.

Let me repeat it: Cyrus’s purchase was not an award. He bought shares on the open market for $100,000. Who the heck has that kind of money? Who would buy CYDY shares now? Better yet, why?

Blueheel1 wrote: “At some point, it will become clear to everyone on here: we are not Nader-land anymore.”

I agree too with his summary: “My understanding is that the FDA had one clarification question from our submission of the hold data,” which they needed to address. It was very minor and it was answered within one to two days. I maintain that the hold will be lifted shortly, (although this probably pushes the scenario out a week to maybe mid-March).

Cyrus will graduate from president to CEO and it is contingent upon the hold being lifted. A partnership for oncology/solid tumor trials will follow shortly after that. Further, the company will change their name this calendar year and totally rebrand - which is appropriate given that Cyrus has fired everyone responsible for its mismanagement.

They will also start a Nash trial this year. Nash is a huge market and there is room for 5-6 players (similar to type 2 diabetes) – AND we will be one of them.

We will win an award against Amarex this year. It will be north of FIFTY MILLION!

ALSO, and I shout his sentiment from the rooftops: Add shares at these levels if you have the $.